Cadmus Rich, M.D., is Chief Medical Officer and Head of Research and Development at Aura. Before joining Aura, Cadmus was most recently Vice President of Clinical Development and Medical Affairs at Inotek Pharmaceuticals. He previously held several senior positions at Alcon Laboratories, including overseeing the pipeline strategy and R&D projects for Alcon’s intraocular lens product line, and leading global pharmaceutical clinical trial management. Cadmus was board-certified in Ophthalmology in 2002 after completing his residency at the UNC School of Medicine. He obtained his MBA from Regis University, his Certified Physician Executive certification from the American Association for Physician Leadership and his BA in Psychology from Case Western Reserve University.
Cadmus has extensive experience in R&D, having led or participated in nearly 75 development programs including the submission and approval of multiple devices and pharmaceutical products in the U.S., EU, China, Japan and Brazil/Latin America. He has directly led or participated in over 150 clinical trials across multiple ophthalmology and systemic indications as an executive leader, medical director, medical monitor and principal investigator. Cadmus has served on the board of directors of the North Carolina Specialty Hospital and is currently a member of the board of directors of Prevent Blindness, the nation’s longest-acting volunteer eye health and safety organization.